Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction Towards an understanding of factors influencing clinical practice

@inproceedings{Woods1997BetablockersAA,
  title={Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction Towards an understanding of factors influencing clinical practice},
  author={Kent L Woods and Diane Ketley and Adam Lowy and Ant{\`o}nia Agust{\'i} and C. Hagn and Risto Kala and Nicolas Karatzas and Alain Leizorowicz and Aasmund Reikvam and Julian Schilling and Ricardo J. Seabra-Gomes and Donatas Vasiliauskas and Lars Wilhelmsen},
  year={1997}
}
Aims Long-term beta-blockade reduced mortality after acute myocardial infarction by about a quarter in a series of published trials. Representative data on beta-blocker use for secondary prevention are scanty but indicate wide variations. We have analysed European practice, and sources of variation, by regional sampling of acute myocardial infarction patients admitted to hospital in 11 countries during the period January 1993–June 1994. 
17 Citations
19 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Acute myocardial infarction : pre - hospital and in - hospital management

  • M Eccles, C Bradshaw
  • Eur Heart J
  • 1996

Trans - lation of clinical trials into practice : a European population - based study of the use of thrombolysis for acute myocardial infarction

  • S Viskin, I Kitzis, E Lev
  • Lancet
  • 1996

Similar Papers

Loading similar papers…